2-Oxo-PCE, also known by its chemical name eticyclidone, is a synthetic dissociative substance belonging to the arylcyclohexylamine class. It is closely related to compounds such as ketamine, MXE, and PCP. Its primary mechanism of action involves antagonism of the NMDA (N-methyl-D-aspartate) receptor, which leads to altered perceptions of body, mind, and space. This compound is not approved for human consumption and is typically used in laboratory research, neurochemical modeling, and psychonautical studies to explore the nature of consciousness, memory modulation, and dissociative effects.

• Acts as a potent NMDA receptor antagonist, meaning it blocks excitatory neurotransmission that is normally mediated by glutamate. This causes dissociative and anesthetic-like effects that are useful in studying neural connectivity and consciousness.

• Used in psychonautical and neuropsychological research to analyze subjective dissociation, ego dissolution, and memory segmentation. It is favored in cognitive mapping and exploratory neuroscience studies.

• Available in crystalline or powder form, with an off-white to pale yellow appearance. This makes it stable for long-term storage and easy to measure for precise applications.

• Commonly studied in contrast with other dissociatives, especially ketamine and MXE, due to its unique profile: more clarity, longer duration, and a greater tendency toward introspective effects.

• Offers a more mentally coherent dissociative state, which researchers believe makes it an ideal subject for memory testing, dream analysis, and consciousness exploration.

• Typically administered orally, nasally, or sublingually in lab simulations, though all uses remain experimental and should follow ethical research practices.

• Not classified as a pharmaceutical or therapeutic agent, which means it cannot be legally marketed as a medical treatment or supplement in any jurisdiction.

The effects of 2-Oxo-PCE are dissociative and psychoactive in nature, with a wide range of subjective and neurophysiological outcomes depending on dosage and individual neurochemistry. While related compounds like ketamine induce a foggier or sedated dissociation, 2-Oxo-PCE is often described as more lucid and clear-headed, even during intense sessions. Researchers value this profile for examining ego detachment and cognitive architecture.

• Dissociation from physical environment and self is one of the defining effects. Subjects may experience detachment from their body, surroundings, or ordinary sense of time and space.

• Enhanced introspection and philosophical insight have been commonly reported. Users often describe deep analytical thought processes and emotional distancing, making it ideal for studying identity and perception.

• Mild visual distortions or sensory layering can occur at mid to high doses, including blurred vision, depth misperception, or light tracers. These effects are useful for visual cognition research.

• Cognitive enhancement or clarity at low doses, unlike other dissociatives that often impair logical reasoning. 2-Oxo-PCE allows researchers to explore altered states without significant disorientation in some cases.

• Ego dissolution at high doses, where personal identity may temporarily blur into a neutral observational perspective. This is significant in studies of self-perception and non-dual awareness.

• Time dilation or temporal looping is common, where time appears to slow down or repeat. These effects are closely studied in the context of episodic memory and mental chronometry.

• Physiological effects such as increased heart rate or mild numbness can also accompany the mental shifts, especially during the come-up or peak phase.

The legality of 2-Oxo-PCE is complex and varies greatly by jurisdiction. While it is not listed under the United Nations’ international drug control treaties, individual countries have enacted their own laws regarding dissociative substances and analogues. Buyers and researchers should always verify their local laws before attempting to import or possess this compound.

• In the United States, 2-Oxo-PCE is unscheduled at the federal level, but may fall under the Federal Analog Act if intended for human consumption. Some states have enacted analogue or research chemical bans that apply to compounds like this.

• The United Kingdom classifies 2-Oxo-PCE as a Class B drug under the Psychoactive Substances Act, making its sale or possession illegal without a license.

• Germany, Sweden, and Finland have banned 2-Oxo-PCE explicitly, listing it among their controlled narcotic substances.

• Canada and Australia have no direct scheduling for 2-Oxo-PCE, but it could be considered an analogue of controlled substances like ketamine or PCP, which may lead to seizure or legal interpretation by customs.

• Some countries in Eastern Europe, South America, and Asia may still allow research chemical sales, provided it is not marketed for human consumption.

• Psycho Plug ships using stealth packaging to minimize interception and customs scrutiny, but we always advise our customers to check their local regulations before ordering.

• Legality can change frequently, so it’s essential to stay informed through government publications or legal counsel in your region.

Though 2-Oxo-PCE and ketamine are chemically related, their subjective and pharmacological profiles differ in several significant ways. While both are arylcyclohexylamines that act primarily on NMDA receptors, their effects on cognition, clarity, body load, and duration make them distinct tools in a research setting.

• 2-Oxo-PCE is generally more potent by weight, meaning lower dosages are needed to reach dissociative states compared to ketamine.

• Longer duration of action is a hallmark of 2-Oxo-PCE, which can last between 3 and 6 hours, whereas ketamine’s effects typically taper off in 1 to 2 hours.

• Cognitive clarity is higher with 2-Oxo-PCE, with many subjects reporting an ability to think and reflect more coherently, unlike ketamine, which can induce dreamlike confusion or “k-holes.”

• Body sedation is stronger in ketamine, making it more suitable for anesthesia but less ideal for cognitive or consciousness studies.

• Ketamine is approved for medical use, including as an anesthetic and in off-label depression therapy, while 2-Oxo-PCE remains strictly a research compound.

• 2-Oxo-PCE has a narrower therapeutic window, with noticeable changes in effect based on small shifts in dosage, requiring more precise measurement.

• Legality and accessibility vary, as ketamine is a controlled medical substance, whereas 2-Oxo-PCE is often unregulated but vulnerable to analog laws.

To maintain the chemical integrity and long-term stability of 2-Oxo-PCE, proper storage is essential. The compound’s molecular structure can degrade under improper environmental conditions such as heat, light, or moisture. Whether you’re storing for short-term use or long-term research archiving, following best practices will ensure its purity remains intact.

• Store in a cool, dry place away from heat sources, such as near air vents, radiators, or sunlight-exposed areas. Temperatures above room temperature may accelerate degradation.

• Use airtight containers made of glass or heavy-duty plastic. This prevents moisture and oxygen from entering and compromising the compound’s stability.

• Avoid direct exposure to light, especially UV light, which can cause chemical breakdown. Opaque or UV-resistant containers are ideal.

• Add a desiccant packet to absorb any residual moisture inside the storage container. Silica gel packets are commonly used for this purpose.

• Label all containers clearly, including compound name, date of acquisition, and concentration or batch number to avoid confusion or misuse.

• For long-term storage, refrigeration is recommended. However, the compound should be kept in a moisture-free environment to avoid condensation.

• Keep out of reach of unauthorized persons, including children and pets. Properly stored 2-Oxo-PCE can maintain its purity for up to 24 months or longer.

Although 2-Oxo-PCE is not intended for human consumption, it is often discussed in research and observational literature for its unique dose-dependent effects. When studied under laboratory conditions, accurate measurement is critical due to the compound’s high potency and narrow margin between threshold and full dissociative effects. Dosing must always be approached with precise instrumentation and scientific caution.

• Threshold effects are observed around 3–5 mg, typically resulting in mild stimulation, subtle cognitive shift, and early-stage dissociation. This dosage is often used to assess base sensitivity or create minimal perceptual changes in research protocols.

• Common research doses range between 5–20 mg, depending on the purpose of the study. This range allows for clear dissociative and introspective states while maintaining mental coherence.

• Doses between 20–40 mg produce pronounced effects, including strong dissociation, time distortion, ego separation, and sensory modulation. These doses require expert handling due to increased risk of confusion or motor incoordination.

• Doses above 40 mg are considered high and unpredictable, with strong likelihood of full sensory disconnection, amnesia, and long recovery periods. These are used only in deep consciousness studies or specific neurochemical impact models.

• Always use a calibrated milligram scale, preferably one accurate to 0.001g. Inaccurate dosing can result in unpredictable and potentially unsafe outcomes in a research setting.

• Dosing may vary based on administration route. Oral administration typically requires slightly higher amounts than intranasal or sublingual due to differences in bioavailability.

• Spacing doses is critical to avoid tolerance buildup, as the body quickly adjusts to NMDA antagonists like 2-Oxo-PCE, which can render subsequent sessions less effective.

The timing of 2-Oxo-PCE’s effects is essential for designing research experiments, especially those requiring structured observation windows. Its duration offers a significant advantage over shorter-acting dissociatives like ketamine, allowing longer uninterrupted study sessions. Onset speed and total duration vary slightly with dose and route of administration.

• Onset typically occurs within 15 to 30 minutes after oral or sublingual exposure. Intranasal administration may reduce this window to as little as 10 minutes.

• Initial effects include light stimulation, altered sensory input, and cognitive shifting, which gradually evolve into deeper dissociative phenomena.

• Peak effects are usually reached around 1–2 hours post-administration, offering a prime window for observation of altered cognition, memory, and spatial perception.

• Total duration averages between 3 to 6 hours, making it ideal for extended neuropsychological or consciousness-based research without the need for redosing.

• After-effects can linger for an additional 1–2 hours, with residual cognitive sharpening or slight fatigue reported in anecdotal data.

• Effects diminish gradually, rather than dropping off sharply, which can help ease integration of experiences and reduce post-study confusion.

• Compared to MXE and 3-MeO-PCP, 2-Oxo-PCE offers a smoother curve, making it more manageable in long-form observation studies.

Standard drug testing protocols used for employment or legal purposes rarely include compounds like 2-Oxo-PCE. However, in specialized medical or forensic screenings, it is possible to detect the presence of 2-Oxo-PCE or its metabolites. Understanding its detectability is important for researchers or individuals under regulatory scrutiny.

• Routine drug panels (5-panel or 10-panel tests) do not test for 2-Oxo-PCE or similar arylcyclohexylamines, as these are designed for substances like THC, opiates, cocaine, amphetamines, and benzodiazepines.

• Advanced toxicological screenings may detect 2-Oxo-PCE, especially if they are designed to search for dissociatives or include LC-MS (liquid chromatography–mass spectrometry) methods.

• The compound is chemically distinct from ketamine, so it typically won’t cause false positives on ketamine tests unless specifically configured to flag related structures.

• Detection windows may last up to several days, depending on the dose, frequency of use, and metabolic rate. Compounds with similar structures have shown presence in urine and blood for up to 72 hours.

• Hair follicle testing may reveal use after several weeks, though this requires highly specialized equipment and is rarely used for unregulated research chemicals.

• Employers and probation systems are unlikely to test for 2-Oxo-PCE, but athletes, forensic cases, or controlled study participants should exercise caution.

• Psycho Plug does not encourage misuse of any product and recommends all customers handle 2-Oxo-PCE in a legal, professional research context.

Although 2-Oxo-PCE is generally well-tolerated in responsible research environments, it carries risks typical of the dissociative class—particularly if misused or used frequently. Understanding its side effects is vital for ethical research design and safe chemical handling.

• Cognitive disorientation or confusion, especially at higher doses, can impair decision-making and memory during peak effects.

• Motor incoordination and balance impairment are common physical effects, similar to those seen with ketamine or alcohol. Researchers should ensure test subjects are in a safe, controlled space.

• Mild nausea or dizziness may occur during the onset phase, particularly with higher doses or when taken on an empty stomach.

• Emotional blunting or temporary depersonalization, where the user feels detached from thoughts or surroundings, is reported and should be carefully observed.

• Potential for urinary tract discomfort has been noted with frequent or long-term use of arylcyclohexylamines, though data on 2-Oxo-PCE specifically is limited.

• Short-term memory disruption can happen during the peak phase. This effect typically resolves as the substance leaves the system but may hinder complex cognitive tasks temporarily.

• No confirmed cases of physical addiction, though psychological dependence and tolerance are risks with repeated exposure.

• Combining with depressants or stimulants increases health risks, such as seizure potential or respiratory suppression.

2-Oxo-PCE does not appear to produce strong physical dependence in documented research, but like many psychoactive substances, it can lead to psychological reinforcement and habitual use. Dissociatives are known to develop tolerance quickly, which contributes to patterns of repeated use in unsupervised environments. For responsible study, these factors must be monitored closely.

• Physical withdrawal symptoms have not been documented, suggesting a low potential for physiological addiction compared to opioids or stimulants.

• Tolerance builds rapidly with repeated exposure, often within two or three consecutive uses. This means larger doses are needed to achieve similar effects, increasing risk of side effects.

• Psychological craving can develop, especially in individuals using the substance for escapism or emotional avoidance, rather than structured observation.

• Spacing out sessions is crucial to maintain efficacy and avoid building tolerance or dependency. A period of at least one week between uses is generally recommended.

• Subjects may become fixated on the dissociative state, particularly if using high doses for introspection, which can evolve into a behavioral pattern.

• No formal addiction treatment protocols exist for 2-Oxo-PCE, due to its status as a research chemical, making prevention and awareness even more important.

• Usage should always be documented and regulated, preferably with logs and observation records to ensure frequency and dosage remain within ethical bounds.

The subjective effects of 2-Oxo-PCE are often described as uniquely clear-headed and introspective compared to other dissociatives. While many substances in this class produce fogginess or confusion, 2-Oxo-PCE maintains cognitive clarity during much of the experience. The sensations reported during research simulations vary with dose and route, but generally include a combination of detachment, analytical thought, and altered sensory processing.

• Light stimulation and alertness are common at low doses, with users reporting enhanced focus, abstract thinking, and emotional neutrality. This phase resembles mild nootropic effects, making it useful for studying attention and cognition.

• Body-lightness or numbness typically sets in next, where subjects feel a loss of physical grounding or weight. This is a classic dissociative trait, often used to explore proprioception and bodily awareness.

• Mental separation from surroundings intensifies as the dose increases, producing a sensation of “floating” or observing oneself from a distance. Researchers often use this effect in studies of depersonalization or self-concept.

• Ego dissolution can occur at higher doses, where the subject temporarily loses the boundary between self and environment. This is useful in consciousness and spiritual experience studies but may also induce anxiety in untrained participants.

• Time distortion is a prominent feature, where time may appear to slow down, speed up, or loop. This can lead to a deep exploration of temporal perception and memory anchoring.

• Visual distortions, such as tracers, pattern overlays, or depth warping, may accompany the experience, especially in low-light settings or when the subject is still.

• Verbal fluency and internal dialogue remain more intact than with ketamine, enabling continued communication and reflective thought throughout the session.

Mixing 2-Oxo-PCE with other substances is not recommended and can result in dangerous interactions or unpredictable effects. As a potent NMDA antagonist, it alters key neurotransmitter systems and amplifies or destabilizes the effects of many drugs. In a research or exploratory context, combining it with other compounds can introduce serious confounds and safety risks.

• Combining with depressants like alcohol or benzodiazepines increases the risk of respiratory depression, blackouts, or loss of motor control. This is especially hazardous at higher doses of either substance.

• Stimulant combinations may cause anxiety, confusion, or cardiovascular strain, particularly due to increased heart rate and the opposing action of excitatory neurotransmitters.

• Classic psychedelics (LSD, psilocybin, DMT) may enhance or distort the dissociative experience. While some anecdotal reports describe synergy, such combinations can also result in panic, derealization, or disorientation.

• Opioids and 2-Oxo-PCE should never be mixed, as they both affect CNS activity and can lead to respiratory suppression or loss of consciousness.

• Cannabis may intensify dissociative and hallucinatory effects, though reactions vary greatly between individuals. Some researchers find it increases emotional blunting or paranoia.

• Unknown synergistic effects exist, as 2-Oxo-PCE is a relatively under-studied compound. Mixing with untested combinations increases the risk of adverse reactions.

• Always isolate 2-Oxo-PCE use in research to maintain control and accuracy in experimental outcomes.

Though often compared, 2-Oxo-PCE and MXE (Methoxetamine) are chemically distinct and produce noticeably different effects. Both belong to the arylcyclohexylamine family and act as NMDA antagonists, but their structure, duration, and subjective profile differ in key ways. These differences are especially important for researchers aiming to distinguish between clarity-focused and euphoric dissociatives.

• 2-Oxo-PCE is typically more stimulating and cerebral, while MXE is more euphoric and sedating. This makes 2-Oxo-PCE more suitable for analytical research, whereas MXE was often used in introspective or emotional contexts.

• MXE contains a methoxy group, which alters its interaction with serotonin transporters and may contribute to its warm, empathogenic effects.

• Duration of action is similar, with both substances lasting 4–6 hours, though MXE often has a longer afterglow period.

• MXE has been banned in most countries, whereas 2-Oxo-PCE remains legal or unscheduled in many regions. This makes the latter more accessible for research purposes.

• Subjective clarity is higher with 2-Oxo-PCE, making it easier to document and analyze experiences during peak effects.

• MXE was historically popular in the early 2010s, but its prohibition and declining quality control led to the rise of analogs like 2-Oxo-PCE.

• Some users find 2-Oxo-PCE emotionally neutral, while MXE is often described as warm or empathetic. These distinctions may influence study design in affective neuroscience.

2-Oxo-PCE is chemically stable when stored correctly, with a long shelf life that makes it suitable for bulk research supply or long-term archiving. However, improper storage conditions such as heat, moisture, or light exposure can degrade the compound and reduce its potency or consistency. Understanding storage variables is essential for maintaining sample viability.

• Shelf life is typically 24 months or longer, when stored in optimal, low-humidity conditions.

• Proper containers include airtight glass jars or HDPE plastic vials, which prevent oxygen or moisture intrusion.

• Vacuum-sealed bags with desiccant packs offer the highest level of preservation, especially for extended storage or international transit.

• Refrigeration can prolong stability, especially in humid environments. However, condensation must be avoided to prevent moisture damage.

• Exposure to heat may break down molecular structure, especially temperatures above 30°C (86°F). Always store in a cool environment.

• Sunlight or UV exposure will degrade the compound, so opaque or dark containers are recommended for storage.

• Oxidation or discoloration may indicate contamination or age, and such samples should be avoided in critical research applications.

Due to its potency and dissociative nature, 2-Oxo-PCE is generally not recommended for inexperienced users or those unfamiliar with arylcyclohexylamines. Its mental clarity can be misleading, and higher doses may still induce powerful disconnection, confusion, or anxiety. Researchers exploring altered states should start with extreme caution and low dosages.

• Beginners may underestimate its effects, especially at mid-range doses where body detachment can be intense while the mind remains alert.

• Low doses may feel manageable, but effects can escalate quickly with minor increases in quantity. Precision in dosing is essential to avoid overwhelm.

• Unlike ketamine, the effects are more linear, which means there are fewer obvious breaks between phases, making it hard for inexperienced users to gauge onset or peak.

• Lack of prior dissociative experience may lead to confusion or panic, particularly during ego loss or intense spatial distortion.

• There is a risk of physical disorientation, such as stumbling or loss of motor coordination, which can be dangerous without proper supervision.

• Controlled environments are essential, including quiet, familiar surroundings with a clear protocol for safety and observation.

• Supervision by a trained guide or observer is advised, especially for first-time researchers or participants.